From October 1, 2021 to December 31, 2021, the company has repurchased 44,857 shares, representing 0.39% for KRW 435.14 million. With this, the company has completed the repurchase of 44,857 shares, representing 0.39% for KRW 435.14 million under the buyback announced on March 27, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,680 KRW | 0.00% |
|
+1.32% | -18.38% |
1st Jan change | Capi. | |
---|---|---|
-18.38% | 63.07M | |
+20.37% | 43.54B | |
+19.44% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-15.02% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- A001540 Stock
- News Ahn-Gook Pharmaceutical Co., Ltd.
- Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.